XML 44 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheet Details - Accrued Expenses (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Balance Sheet Related Disclosures [Abstract]    
Accrued product returns $ 5,445 $ 3,034
Accrued discounts and allowances 4,239 4,088
Accrued interest expense, current portion 3,033 2,526
Accrued clinical trial costs 1,238 1,012
Accrued sales and marketing costs 1,161 304
Astellas tail payment, current portion 1,131 1,820
Other accrued expenses 2,618 1,559
Accrued expenses $ 18,865 $ 14,343